{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:12:06Z","timestamp":1792548726924,"version":"4.5.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peritoneal dialysis (PD) offers many advantages over hemodialysis but chronic exposure to bio-incompatible glucose-based PD solutions and continuous absorption of glucose from the dialysate may lead to peritoneal membrane (PM) dysfunction and systemic metabolic complications such as hyperglycemia, insulin resistance, dyslipidemia, and obesity. Replacing one daily exchange of 1.36% glucose-based solution with one 1.1% amino acid-based PD solution may provide nutritional benefits of amino acid supplementation, improve biocompatibility, and reduce the peritoneal glucose load while maintaining similar ultrafiltration and solute removal capacity. Randomized clinical trials and mechanistic studies show beneficial effects of amino acid-based PD solutions on peritoneal homeostasis, preserved viability of the PM, and favorable nutritional and metabolic effects. This systematic review highlights the clinical rationale for implementing use of amino acid\u2013based PD solutions as an integral part of glucose-sparing strategies in PD to reduce the cumulative intraperitoneal glucose load and mitigate its well-documented adverse effects. Amino acid\u2013based PD solutions emerge as a clinically viable, glucose-free alternative and a nutritionally beneficial option that can improve the nutritional status of PD patients by providing essential amino acids when used as part of a comprehensive glucose-sparing strategy. Targeted use of these solutions, particularly in malnourished or high-risk patients, represents a personalized approach to optimizing peritoneal dialysis outcomes.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical trial number:<\/jats:bold>\n                    Not applicable.\n                  <\/jats:p>","DOI":"10.1186\/s12882-026-05222-3","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:14:04Z","timestamp":1785420844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic potential of amino acid-based peritoneal dialysis solutions: a systematic review"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-4293","authenticated-orcid":false,"given":"Bengt","family":"Lindholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Barbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Heider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-588X","authenticated-orcid":false,"given":"Rumeyza","family":"Kazancioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Lichodziejewska-Niemierko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9627-908X","authenticated-orcid":false,"given":"Anabela","family":"Malho-Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Parikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Quevedo-Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adonay","family":"Santana-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya","family":"Udayaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"5222_CR1","doi-asserted-by":"crossref","unstructured":"Perl J, Brown EA, Chan CT et al. Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023;103(5):842\u2013858.","DOI":"10.1016\/j.kint.2023.01.006"},{"issue":"11","key":"5222_CR2","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","volume":"27","author":"R Mehrotra","year":"2016","unstructured":"Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The Current State of Peritoneal Dialysis. J Am Soc Nephrol. 2016;27(11):3238\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"5222_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/ndt\/gfaf171","volume":"41","author":"MF Slon-Roblero","year":"2026","unstructured":"Slon-Roblero MF, Stel VS, Sanchez-Alvarez E, et al. Trends in home dialysis over the last decade in Europe: an ERA Registry study. Nephrol Dial Transpl. 2026;41(3):457\u201375.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"5222_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3747\/pdi.2015.00218","volume":"36","author":"PG Lan","year":"2016","unstructured":"Lan PG, Clayton PA, Johnson DW, et al. Duration of Hemodialysis Following Peritoneal Dialysis Cessation in Australia and New Zealand: Proposal for a Standardized Definition of Technique Failure. Perit Dial Int. 2016;36(6):623\u201330.","journal-title":"Perit Dial Int"},{"issue":"1","key":"5222_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/ndt\/13.1.154","volume":"13","author":"RJ Rigby","year":"1998","unstructured":"Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transpl. 1998;13(1):154\u20139.","journal-title":"Nephrol Dial Transpl"},{"key":"5222_CR6","doi-asserted-by":"crossref","unstructured":"Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl. 2003;(84):S158\u201361.","DOI":"10.1046\/j.1523-1755.63.s84.46.x"},{"issue":"6","key":"5222_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/089686080902900602","volume":"29","author":"EA Brown","year":"2009","unstructured":"Brown EA, Van Biesen W, Finkelstein FO, et al. ISPD Working Party. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int. 2009;29(6):595\u2013600.","journal-title":"Perit Dial Int"},{"issue":"12","key":"5222_CR8","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1093\/ndt\/gfs314","volume":"27","author":"DW Johnson","year":"2012","unstructured":"Johnson DW, Brown FG, Clarke M, et al. balANZ Trial Investigators. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial. Nephrol Dial Transpl. 2012;27(12):4445\u201353.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"5222_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3747\/pdi.2017.00018","volume":"37","author":"EA Brown","year":"2017","unstructured":"Brown EA, Bargman J, van Biesen W, et al. Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update. Perit Dial Int. 2017;37(4):362\u201374.","journal-title":"Perit Dial Int"},{"issue":"7","key":"5222_CR10","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/ndt\/gfq213","volume":"25","author":"JM Bargman","year":"2010","unstructured":"Bargman JM. Slouching towards Bethlehem: the beast of biocompatibility. Nephrol Dial Transpl. 2010;25(7):2050\u20131.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"5222_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12882-025-04732-w","volume":"27","author":"B Lindholm","year":"2026","unstructured":"Lindholm B, Barbari A, Allen J, et al. Clinical rationale behind glucose-sparing strategies in peritoneal dialysis: a narrative review. BMC Nephrol. 2026;27(1):80. https:\/\/doi.org\/10.1186\/s12882-025-04732-w.","journal-title":"BMC Nephrol"},{"issue":"1","key":"5222_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.semnephrol.2016.10.005","volume":"37","author":"CC Szeto","year":"2017","unstructured":"Szeto CC, Johnson DW. Low GDP Solution and Glucose-Sparing Strategies for Peritoneal Dialysis. Semin Nephrol. 2017;37(1):30\u201342.","journal-title":"Semin Nephrol"},{"key":"5222_CR13","doi-asserted-by":"publisher","first-page":"812609","DOI":"10.1155\/2012\/812609","volume":"2012","author":"Y Cho","year":"2012","unstructured":"Cho Y, Badve SV, Hawley CM, Wiggins K, Johnson DW. Biocompatible peritoneal dialysis fluids: clinical outcomes. Int J Nephrol. 2012;2012:812609. https:\/\/doi.org\/10.1155\/2012\/812609.","journal-title":"Int J Nephrol"},{"key":"5222_CR14","doi-asserted-by":"publisher","unstructured":"Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev. 2014;(3):CD007554. https:\/\/doi.org\/10.1002\/14651858.CD007554.pub2. Update in: Cochrane Database Syst Rev. 2018;10:CD007554. doi: 10.1002\/14651858.CD007554.pub3.","DOI":"10.1002\/14651858.CD007554.pub2"},{"issue":"1","key":"5222_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5527\/wjn.v4.i1.92","volume":"4","author":"A Qayyum","year":"2015","unstructured":"Qayyum A, Oei EL, Paudel K, Fan SL. Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions. World J Nephrol. 2015;4(1):92\u20137.","journal-title":"World J Nephrol"},{"key":"5222_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000450690","volume":"189","author":"M Nataatmadja","year":"2017","unstructured":"Nataatmadja M, Cho Y, Johnson DW. Evidence for Biocompatible Peritoneal Dialysis Solutions. Contrib Nephrol. 2017;189:91\u2013101.","journal-title":"Contrib Nephrol"},{"issue":"10","key":"5222_CR17","doi-asserted-by":"publisher","first-page":"CD007554","DOI":"10.1002\/14651858.CD007554.pub3","volume":"10","author":"H Htay","year":"2018","unstructured":"Htay H, Johnson DW, Wiggins KJ, et al. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev. 2018;10(10):CD007554. https:\/\/doi.org\/10.1002\/14651858.CD007554.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"5222_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/089686089301300309","volume":"13","author":"CB Nilsson-Thorell","year":"1993","unstructured":"Nilsson-Thorell CB, Muscalu N, Andr\u00e9n AH, Kjellstrand PT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int. 1993;13(3):208\u201313.","journal-title":"Perit Dial Int"},{"issue":"6","key":"5222_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1053\/j.ajkd.2017.10.017","volume":"71","author":"H Htay","year":"2018","unstructured":"Htay H, Cho Y, Pascoe EM, et al. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry. Am J Kidney Dis. 2018;71(6):814\u201321.","journal-title":"Am J Kidney Dis"},{"key":"5222_CR20","first-page":"57","volume":"12","author":"A Wieslander","year":"1996","unstructured":"Wieslander A, Forsb\u00e4ck G, Svensson E, Lind\u00e9n T, Cytotoxicity. pH, and glucose degradation products in four different brands of PD fluid. Adv Perit Dial. 1996;12:57\u201360.","journal-title":"Adv Perit Dial"},{"issue":"1","key":"5222_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ki.1997.22","volume":"51","author":"M Nakayama","year":"1997","unstructured":"Nakayama M, Kawaguchi Y, Yamada K, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int. 1997;51(1):182\u20136.","journal-title":"Kidney Int"},{"issue":"6","key":"5222_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/089686089901900605","volume":"19","author":"MA Mateijsen","year":"1999","unstructured":"Mateijsen MA, van der Wal AC, Hendriks PM, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int. 1999;19(6):517\u201325.","journal-title":"Perit Dial Int"},{"issue":"2","key":"5222_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/039139880502800203","volume":"28","author":"C Pollock","year":"2005","unstructured":"Pollock C. Pathogenesis of peritoneal sclerosis. Int J Artif Organs. 2005;28(2):90\u20136.","journal-title":"Int J Artif Organs"},{"key":"5222_CR24","unstructured":"Adib N, Shekarchi M, Hajimehdipoor H, Shalviri G, Shekarchi M, Imaninejad M. Cytotoxic glucose degradation products in fluids for peritoneal dialysis. Iran J Pharm Res. 2011 Winter;10(1):113\u20137."},{"issue":"6","key":"5222_CR25","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1046\/j.1523-1755.1998.00178.x","volume":"54","author":"A J\u00f6rres","year":"1998","unstructured":"J\u00f6rres A, Bender TO, Finn A, et al. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int. 1998;54(6):2184\u201393.","journal-title":"Kidney Int"},{"issue":"1","key":"5222_CR26","first-page":"42","volume":"17","author":"N Topley","year":"1997","unstructured":"Topley N. In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions. Perit Dial Int. 1997;17(1):42\u20137.","journal-title":"Perit Dial Int"},{"issue":"9","key":"5222_CR27","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.2215\/CJN.12361212","volume":"8","author":"Y Cho","year":"2013","unstructured":"Cho Y, Badve SV, Hawley CM, et al. Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes. Clin J Am Soc Nephrol. 2013;8(9):1556\u201363.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"5222_CR28","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.2337\/diabetes.54.8.2424","volume":"54","author":"P Justo","year":"2005","unstructured":"Justo P, Sanz AB, Egido J, Ortiz A. 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes. 2005;54(8):2424\u20139.","journal-title":"Diabetes"},{"issue":"7","key":"5222_CR29","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3747\/pdi.2012.00331","volume":"34","author":"EY Seo","year":"2014","unstructured":"Seo EY, An SH, Cho JH, et al. Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials. Perit Dial Int. 2014;34(7):724\u201331.","journal-title":"Perit Dial Int"},{"key":"5222_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000422285","volume":"103","author":"B Lindholm","year":"1993","unstructured":"Lindholm B, Park MS, Bergstr\u00f6m J. Supplemented dialysis: amino acid-based solutions in peritoneal dialysis. Contrib Nephrol. 1993;103:168\u201382.","journal-title":"Contrib Nephrol"},{"key":"5222_CR31","first-page":"S81","volume":"56","author":"B Faller","year":"1996","unstructured":"Faller B. Amino acid-based peritoneal dialysis solutions. Kidney Int Suppl. 1996;56:S81\u20135.","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"5222_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40620-020-00804-2","volume":"34","author":"M Bonomini","year":"2021","unstructured":"Bonomini M, Zammit V, Divino-Filho JC, et al. The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis. J Nephrol. 2021;34(2):503\u201319.","journal-title":"J Nephrol"},{"issue":"6","key":"5222_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5414\/CNP58445","volume":"58","author":"GS Taylor","year":"2002","unstructured":"Taylor GS, Patel V, Spencer S, Fluck RJ, McIntyre CW. Long-term use of 1.1% amino acid dialysis solution in hypoalbuminemic continuous ambulatory peritoneal dialysis patients. Clin Nephrol. 2002;58(6):445\u201350.","journal-title":"Clin Nephrol"},{"issue":"1","key":"5222_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2215\/CJN.01370406","volume":"2","author":"HL Tjiong","year":"2007","unstructured":"Tjiong HL, Rietveld T, Wattimena JL, et al. Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding. Clin J Am Soc Nephrol. 2007;2(1):74\u201380.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5222_CR35","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700.","journal-title":"BMJ"},{"issue":"11","key":"5222_CR36","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jclinepi.2013.06.004","volume":"66","author":"M Petticrew","year":"2013","unstructured":"Petticrew M, Anderson L, Elder R, et al. Complex interventions and their implications for systematic reviews: a pragmatic approach. J Clin Epidemiol. 2013;66(11):1209\u201314.","journal-title":"J Clin Epidemiol"},{"issue":"7710","key":"5222_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/d41586-018-05414-4","volume":"558","author":"CA Donnelly","year":"2018","unstructured":"Donnelly CA, Boyd I, Campbell P, et al. Four principles to make evidence synthesis more useful for policy. Nature. 2018;558(7710):361\u20134.","journal-title":"Nature"},{"key":"5222_CR38","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","volume":"368","author":"M Campbell","year":"2020","unstructured":"Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890. https:\/\/doi.org\/10.1136\/bmj.l6890.","journal-title":"BMJ"},{"issue":"1","key":"5222_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0193841X16674421","volume":"41","author":"JC Valentine","year":"2017","unstructured":"Valentine JC, Wilson SJ, Rindskopf D, et al. Synthesizing Evidence in Public Policy Contexts: The Challenge of Synthesis When There Are Only a Few Studies. Eval Rev. 2017;41(1):3\u201326.","journal-title":"Eval Rev"},{"key":"5222_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2018.08.019","volume":"105","author":"M Campbell","year":"2019","unstructured":"Campbell M, Katikireddi SV, Sowden A, Thomson H. Lack of transparency in reporting narrative synthesis of quantitative data: a methodological assessment of systematic reviews. J Clin Epidemiol. 2019;105:1\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"5222_CR41","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583.","journal-title":"PLoS Med"},{"issue":"4","key":"5222_CR42","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/ki.1995.164","volume":"47","author":"JD Kopple","year":"1995","unstructured":"Kopple JD, Bernard D, Messana J, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995;47(4):1148\u201357.","journal-title":"Kidney Int"},{"key":"5222_CR43","first-page":"311","volume":"12","author":"M Misra","year":"1996","unstructured":"Misra M, Ashworth J, Reaveley DA, Muller B, Brown EA. Nutritional effects of amino acid dialysate (Nutrineal) in CAPD patients. Adv Perit Dial. 1996;12:311\u20134.","journal-title":"Adv Perit Dial"},{"issue":"5","key":"5222_CR44","first-page":"295","volume":"45","author":"CE Douma","year":"1996","unstructured":"Douma CE, de Waart DR, Struijk DG, Krediet RT. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Clin Nephrol. 1996;45(5):295\u2013302.","journal-title":"Clin Nephrol"},{"issue":"3","key":"5222_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/089686089701700312","volume":"17","author":"M Misra","year":"1997","unstructured":"Misra M, Reaveley DA, Ashworth J, Muller B, Seed M, Brown EA. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1997;17(3):279\u201386.","journal-title":"Perit Dial Int"},{"issue":"2","key":"5222_CR46","first-page":"28","volume":"24","author":"M Steele","year":"1998","unstructured":"Steele M, Yokum D, Armstrong A. Efficacy of intraperitoneal amino acid (IPAA) dialysate in an Asian vegetarian patient with chronic hypoalbuminaemia. EDTNA ERCA J. 1998;24(2):28\u201332.","journal-title":"EDTNA ERCA J"},{"issue":"2","key":"5222_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/089686089801800211","volume":"18","author":"MR Jones","year":"1998","unstructured":"Jones MR, Gehr TW, Burkart JM, et al. Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution. Perit Dial Int. 1998;18(2):210\u20136.","journal-title":"Perit Dial Int"},{"issue":"1","key":"5222_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1525-1594.1998.06022.x","volume":"22","author":"L Martis","year":"1998","unstructured":"Martis L, Chen C, Moberly JB. Peritoneal dialysis solutions for the 21st century. Artif Organs. 1998;22(1):13\u20136.","journal-title":"Artif Organs"},{"issue":"5","key":"5222_CR49","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0272-6386(98)70131-3","volume":"32","author":"M Jones","year":"1998","unstructured":"Jones M, Hagen T, Boyle CA, et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis. 1998;32(5):761\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"5222_CR50","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.1999.00723.x","volume":"56","author":"J Delarue","year":"1999","unstructured":"Delarue J, Maingourd C, Objois M, et al. Effects of an amino acid dialysate on leucine metabolism in continuous ambulatory peritoneal dialysis patients. Kidney Int. 1999;56(5):1934\u201343.","journal-title":"Kidney Int"},{"issue":"5","key":"5222_CR51","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/089686089901900504","volume":"19","author":"J Plum","year":"1999","unstructured":"Plum J, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose\/bicarbonate and glucose\/lactate solutions: an intraindividual randomized study. Perit Dial Int. 1999;19(5):418\u201328.","journal-title":"Perit Dial Int"},{"issue":"Suppl 5","key":"5222_CR52","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1177\/089686080002005S10","volume":"20","author":"SH Chung","year":"2000","unstructured":"Chung SH, Stenvinkel P, Bergstr\u00f6m J, Lindholm B. Biocompatibility of new peritoneal dialysis solutions: what can we hope to achieve? Perit Dial Int. 2000;20(Suppl 5):S57\u201367.","journal-title":"Perit Dial Int"},{"issue":"1","key":"5222_CR53","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1523-1755.2001.00499.x","volume":"59","author":"A Wery\u0144ski","year":"2001","unstructured":"Wery\u0144ski A, Waniewski J, Wang T, Anderstam B, Lindholm B, Bergstr\u00f6m J. Kinetic studies of dipeptide-based and amino acid-based peritoneal dialysis solutions. Kidney Int. 2001;59(1):363\u201371.","journal-title":"Kidney Int"},{"issue":"1","key":"5222_CR54","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0272-6386(03)00421-9","volume":"42","author":"FK Li","year":"2003","unstructured":"Li FK, Chan LY, Woo JC, et al. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis. 2003;42(1):173\u201383.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"5222_CR55","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/ndt\/gfg096","volume":"18","author":"TM Chan","year":"2003","unstructured":"Chan TM, Leung JK, Sun Y, Lai KN, Tsang RC, Yung S. Different effects of amino acid-based and glucose-based dialysate from peritoneal dialysis patients on mesothelial cell ultrastructure and function. Nephrol Dial Transpl. 2003;18(6):1086\u201394.","journal-title":"Nephrol Dial Transpl"},{"issue":"Suppl 2","key":"5222_CR56","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1177\/089686080302302s10","volume":"23","author":"JM Chang","year":"2003","unstructured":"Chang JM, Chen HC, Hwang SJ, Tsai JC, Lai YH. Does amino acid-based peritoneal dialysate change homocysteine metabolism in continuous ambulatory peritoneal dialysis patients? Perit Dial Int. 2003;23(Suppl 2):S48\u201351.","journal-title":"Perit Dial Int"},{"issue":"6","key":"5222_CR57","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1177\/089686080402400619","volume":"24","author":"M Voges","year":"2004","unstructured":"Voges M, Faict D, Lechien G, Taminne M. Stability of drug additives in peritoneal dialysis solutions in a new container. Perit Dial Int. 2004;24(6):590\u20135.","journal-title":"Perit Dial Int"},{"key":"5222_CR58","first-page":"170","volume":"20","author":"CY le Poole","year":"2004","unstructured":"le Poole CY, van Ittersum FJ, Weijmer MC, Valentijn RM, ter Wee PM. Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study. Adv Perit Dial. 2004;20:170\u20136.","journal-title":"Adv Perit Dial"},{"issue":"3","key":"5222_CR59","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/j.1523-1755.2004.00879.x","volume":"66","author":"S Mortier","year":"2004","unstructured":"Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int. 2004;66(3):1257\u201365.","journal-title":"Kidney Int"},{"issue":"4","key":"5222_CR60","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/089686080402400414","volume":"24","author":"D Reimann","year":"2004","unstructured":"Reimann D, Dachs D, Meye C, Gross P. Amino acid-based peritoneal dialysis solution stimulates mesothelial nitric oxide production. Perit Dial Int. 2004;24(4):378\u201384.","journal-title":"Perit Dial Int"},{"issue":"5","key":"5222_CR61","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1681\/ASN.2004050402","volume":"16","author":"HL Tjiong","year":"2005","unstructured":"Tjiong HL, van den Berg JW, Wattimena JL, et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol. 2005;16(5):1486\u201393.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"5222_CR62","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/089686080502500509","volume":"25","author":"TA Martikainen","year":"2005","unstructured":"Martikainen TA, Teppo AM, Gr\u00f6nhagen-Riska C, Ekstrand AV. Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane? Perit Dial Int. 2005;25(5):453\u201360.","journal-title":"Perit Dial Int"},{"issue":"1","key":"5222_CR63","doi-asserted-by":"publisher","first-page":"c57","DOI":"10.1159\/000101485","volume":"106","author":"M Duranay","year":"2007","unstructured":"Duranay M, Kanbay M, Turgut F, Altay M, Akcay A. Comparison of incidence of peritonitis between peritoneal dialysis solution types. Nephron Clin Pract. 2007;106(1):c57\u201360.","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"5222_CR64","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/sj.ki.5002364","volume":"72","author":"HL Tjiong","year":"2007","unstructured":"Tjiong HL, Fieren MW, Rietveld T, et al. Albumin and whole-body protein synthesis respond differently to intraperitoneal and oral amino acids. Kidney Int. 2007;72(3):364\u20139.","journal-title":"Kidney Int"},{"issue":"2","key":"5222_CR65","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000100999","volume":"27","author":"JM Chang","year":"2007","unstructured":"Chang JM, Lin SP, Lai YH, Chen HC. Effects of glucose-free dialysis solutions on human peritoneal mesothelial cells. Am J Nephrol. 2007;27(2):206\u201311.","journal-title":"Am J Nephrol"},{"issue":"6","key":"5222_CR66","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3109\/0886022X.2010.485287","volume":"32","author":"E Dervisoglu","year":"2010","unstructured":"Dervisoglu E, Ozdemir O, Yilmaz A. Commencing peritoneal dialysis with 1.1% amino acid solution does not influence biochemical nutritional parameters in incident CAPD patients. Ren Fail. 2010;32(6):653\u20138.","journal-title":"Ren Fail"},{"issue":"2","key":"5222_CR67","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3747\/pdi.2014.00125","volume":"35","author":"S Yung","year":"2015","unstructured":"Yung S, Lui SL, Ng CK, et al. Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers. Perit Dial Int. 2015;35(2):147\u201358.","journal-title":"Perit Dial Int"},{"issue":"11","key":"5222_CR68","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s10096-015-2477-8","volume":"34","author":"M Kussmann","year":"2015","unstructured":"Kussmann M, Schuster L, Zeitlinger M, et al. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis. Eur J Clin Microbiol Infect Dis. 2015;34(11):2257\u201363.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"5222_CR69","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12192-013-0410-6","volume":"18","author":"K Rusai","year":"2013","unstructured":"Rusai K, Herzog R, Kuster L, Kratochwill K, Aufricht C. GSK-3\u03b2 inhibition protects mesothelial cells during experimental peritoneal dialysis through upregulation of the heat shock response. Cell Stress Chaperones. 2013;18(5):569\u201379.","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"5222_CR70","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/s41598-020-58391-y","volume":"10","author":"S Tobudic","year":"2020","unstructured":"Tobudic S, Prager I, Kussmann M, et al. Compatibility of aztreonam in four commercial peritoneal dialysis fluids. Sci Rep. 2020;10(1):1788. https:\/\/doi.org\/10.1038\/s41598-020-58391-y.","journal-title":"Sci Rep"},{"issue":"11","key":"5222_CR71","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s10096-017-3051-3","volume":"36","author":"M Kussmann","year":"2017","unstructured":"Kussmann M, Baumann A, Hauer S, et al. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. Eur J Clin Microbiol Infect Dis. 2017;36(11):2237\u201342.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"5222_CR72","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/08968608211035964","volume":"42","author":"O Iyasere","year":"2022","unstructured":"Iyasere O, Nagar R, Jesus-Silva JA, et al. The impact of amino acid dialysate on anthropometric measures in adult patients on peritoneal dialysis: A systematic review and meta-analysis. Perit Dial Int. 2022;42(3):314\u201323.","journal-title":"Perit Dial Int"},{"issue":"7","key":"5222_CR73","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s40620-023-01716-7","volume":"36","author":"CW Ling","year":"2023","unstructured":"Ling CW, Sud K, Patel R, et al. Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility. J Nephrol. 2023;36(7):1841\u201359.","journal-title":"J Nephrol"},{"issue":"7572","key":"5222_CR74","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/s0140-6736(68)92461-6","volume":"2","author":"J Gjessing","year":"1968","unstructured":"Gjessing J. Addition of aminoacids to peritoneal-dialysis fluid. Lancet. 1968;2(7572):812. https:\/\/doi.org\/10.1016\/s0140-6736(68)92461-6.","journal-title":"Lancet"},{"issue":"4","key":"5222_CR75","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/089686089301300404","volume":"13","author":"MS Park","year":"1993","unstructured":"Park MS, Heimb\u00fcrger O, Bergstr\u00f6m J, Waniewski J, Werynski A, Lindholm B. Peritoneal transport during dialysis with amino acid-based solutions. Perit Dial Int. 1993;13(4):280\u20138.","journal-title":"Perit Dial Int"},{"key":"5222_CR76","unstructured":"Product monograph Nutrineal\u2122 PD4 1. 1% Amino Acid Peritoneal Dialysis Solution Available in: https:\/\/www.baxter.ca\/sites\/g\/files\/ebysai1431\/files\/2018-11\/NUTRINEAL_EN.pdf Last accessed November 25, 2025."},{"key":"5222_CR77","unstructured":"Nutrineal\u2122 Summary of Product Characteristics. Available in: https:\/\/assets.hpra.ie\/products\/Human\/15618\/LicenseSPC_PA0167-086-009_18052016115038.pdf Last accessed November 25, 2025."},{"issue":"6","key":"5222_CR78","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/sj.ki.5002109","volume":"71","author":"CW McIntyre","year":"2007","unstructured":"McIntyre CW. Update on peritoneal dialysis solutions. Kidney Int. 2007;71(6):486\u201390. https:\/\/doi.org\/10.1038\/sj.ki.5002109.","journal-title":"Kidney Int"},{"issue":"4","key":"5222_CR79","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nrneph.2012.13","volume":"8","author":"E Garc\u00eda-L\u00f3pez","year":"2012","unstructured":"Garc\u00eda-L\u00f3pez E, Lindholm B, Davies S. An update on peritoneal dialysis solutions. Nat Rev Nephrol. 2012;8(4):224\u201333.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"5222_CR80","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/ndt\/10.8.1432","volume":"10","author":"B Faller","year":"1995","unstructured":"Faller B, Aparicio M, Faict D, et al. Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis. Nephrol Dial Transpl. 1995;10(8):1432\u20137.","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"5222_CR81","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/ndt\/14.7.1715","volume":"14","author":"DH Kang","year":"1999","unstructured":"Kang DH, Yoon KI, Choi KB, et al. Relationship of peritoneal membrane transport characteristics to the nutritional status in CAPD patients. Nephrol Dial Transpl. 1999;14(7):1715\u201322.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"5222_CR82","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ki.5002585","volume":"73","author":"D Fouque","year":"2008","unstructured":"Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391\u20138.","journal-title":"Kidney Int"},{"issue":"7","key":"5222_CR83","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/ndt\/gfq100","volume":"25","author":"W van Biesen","year":"2010","unstructured":"van Biesen W, Heimburger O, Krediet R, et al. ERBP working group on peritoneal dialysis. Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. Nephrol Dial Transpl. 2010;25(7):2052\u201362.","journal-title":"Nephrol Dial Transpl"},{"key":"5222_CR84","doi-asserted-by":"crossref","unstructured":"Cebeci E, Gursu M, Uzun S, Karadag S, Kazancioglu R, Ozturk S. Factors effective on peritoneal phosphorus transport and clearance in peritoneal dialysis patients. Clin Nephrol. 2017;87(2017)(2):76\u201383.","DOI":"10.5414\/CN108954"},{"issue":"2","key":"5222_CR85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5455\/msm.2020.32.-104","volume":"32","author":"S Uncanin","year":"2020","unstructured":"Uncanin S, Serdarevic N, Klapuh N, Haskovic E. Peritoneal Transport Characteristics at the Beginning and in Long Term Peritoneal Dialysis: a Single Center Experience. Mater Sociomed. 2020;32(2):99\u2013104.","journal-title":"Mater Sociomed"},{"issue":"2","key":"5222_CR86","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3747\/pdi.2009.00264","volume":"31","author":"H Qi","year":"2011","unstructured":"Qi H, Xu C, Yan H, Ma J. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials. Perit Dial Int. 2011;31(2):179\u201388.","journal-title":"Perit Dial Int"},{"issue":"Suppl 2","key":"5222_CR87","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1177\/089686080902902S03","volume":"29","author":"S Yung","year":"2009","unstructured":"Yung S, Chan TM. Intrinsic cells: mesothelial cells -- central players in regulating inflammation and resolution. Perit Dial Int. 2009;29(Suppl 2):S21\u20137.","journal-title":"Perit Dial Int"},{"issue":"6","key":"5222_CR88","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/089686080302300604","volume":"23","author":"PJ Margetts","year":"2003","unstructured":"Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int. 2003;23(6):530\u201341.","journal-title":"Perit Dial Int"},{"issue":"7","key":"5222_CR89","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1681\/ASN.2009070694","volume":"21","author":"O Devuyst","year":"2010","unstructured":"Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol. 2010;21(7):1077\u201385.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"5222_CR90","first-page":"262","volume":"6","author":"A Aguilera","year":"2005","unstructured":"Aguilera A, Y\u00e1\u00f1ez-Mo M, Selgas R, S\u00e1nchez-Madrid F, L\u00f3pez-Cabrera M. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. Curr Opin Investig Drugs. 2005;6(3):262\u20138.","journal-title":"Curr Opin Investig Drugs"},{"issue":"3","key":"5222_CR91","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0014-5793(99)01642-7","volume":"463","author":"R Inagi","year":"1999","unstructured":"Inagi R, Miyata T, Yamamoto T, et al. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett. 1999;463(3):260\u20134.","journal-title":"FEBS Lett"},{"issue":"2","key":"5222_CR92","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/089686080202200202","volume":"22","author":"H Ha","year":"2002","unstructured":"Ha H, Cha MK, Choi HN, Lee HB. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int. 2002;22(2):171\u20137.","journal-title":"Perit Dial Int"},{"issue":"3","key":"5222_CR93","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/089686080302300301","volume":"23","author":"AG Welten","year":"2003","unstructured":"Welten AG, Schalkwijk CG, ter Wee PM, Meijer S, van den Born J, Beelen RJ. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response. Perit Dial Int. 2003;23(3):213\u201321.","journal-title":"Perit Dial Int"},{"key":"5222_CR94","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000093505","volume":"150","author":"V Schwenger","year":"2006","unstructured":"Schwenger V. GDP and AGE receptors: mechanisms of peritoneal damage. Contrib Nephrol. 2006;150:77\u201383.","journal-title":"Contrib Nephrol"},{"issue":"4","key":"5222_CR95","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3747\/pdi.2011.00072","volume":"32","author":"R Himmele","year":"2012","unstructured":"Himmele R, Jensen L, Fenn D, Ho CH, Sawin DA, Diaz-Buxo JA. A new neutral-pH low-GDP peritoneal dialysis fluid. Perit Dial Int. 2012;32(4):444\u201352.","journal-title":"Perit Dial Int"},{"issue":"4","key":"5222_CR96","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/clinchem\/36.4.631","volume":"36","author":"N Igaki","year":"1990","unstructured":"Igaki N, Sakai M, Hata H, Oimomi M, Baba S, Kato H. Effects of 3-deoxyglucosone on the Maillard reaction. Clin Chem. 1990;36(4):631\u20134.","journal-title":"Clin Chem"},{"issue":"Suppl 2","key":"5222_CR97","first-page":"S87","volume":"27","author":"TM Chan","year":"2007","unstructured":"Chan TM, Yung S. Studying the effects of new peritoneal dialysis solutions on the peritoneum. Perit Dial Int. 2007;27(Suppl 2):S87\u201393.","journal-title":"Perit Dial Int"},{"key":"5222_CR98","doi-asserted-by":"publisher","first-page":"1331976","DOI":"10.3389\/fphys.2024.1331976","volume":"15","author":"L Sheng","year":"2024","unstructured":"Sheng L, Shan Y, Dai H, et al. Intercellular communication in peritoneal dialysis. Front Physiol. 2024;15:1331976. https:\/\/doi.org\/10.3389\/fphys.2024.1331976.","journal-title":"Front Physiol"},{"issue":"3","key":"5222_CR99","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ndt\/12.3.543","volume":"12","author":"A J\u00f6rres","year":"1997","unstructured":"J\u00f6rres A, Gahl GM, Ludat K, Frei U, Passlick-Deetjen J. In vitro biocompatibility evaluation of a novel bicarbonate-buffered amino-acid solution for peritoneal dialysis. Nephrol Dial Transpl. 1997;12(3):543\u20139.","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"5222_CR100","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00467-008-0834-x","volume":"23","author":"TO Bender","year":"2008","unstructured":"Bender TO, Witowski J, Aufricht C, et al. Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis. Pediatr Nephrol. 2008;23(9):1537\u201343.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"5222_CR101","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3747\/pdi.2013.00010","volume":"35","author":"J B\u00fcchel","year":"2015","unstructured":"B\u00fcchel J, Bartosova M, Eich G, et al. Interference of peritoneal dialysis fluids with cell cycle mechanisms. Perit Dial Int. 2015;35(3):259\u201374.","journal-title":"Perit Dial Int"},{"issue":"12","key":"5222_CR102","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1681\/ASN.2013101079","volume":"25","author":"YT Chen","year":"2014","unstructured":"Chen YT, Chang YT, Pan SY, et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol. 2014;25(12):2847\u2013258.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"5222_CR103","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1177\/089686089801800609","volume":"18","author":"G Garosi","year":"1998","unstructured":"Garosi G, Gaggiotti E, Monaci G, Brardi S, Di Paolo N. Biocompatibility of a peritoneal dialysis solution with amino acids: histological evaluation in the rabbit. Perit Dial Int. 1998;18(6):610\u20139.","journal-title":"Perit Dial Int"},{"issue":"1","key":"5222_CR104","first-page":"26","volume":"74","author":"HF Brulez","year":"1996","unstructured":"Brulez HF, Dekker HA, Oe PL, Verbeelen D, ter Wee PM, Verbrugh HA. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid. Nephron. 1996;74(1):26\u201332.","journal-title":"Nephron"},{"issue":"5","key":"5222_CR105","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1111\/j.1523-1755.2000.00376.x","volume":"58","author":"A Shostak","year":"2000","unstructured":"Shostak A, Wajsbrot V, Gotloib L. High glucose accelerates the life cycle of the in vivo exposed mesothelium. Kidney Int. 2000;58(5):2044\u201352.","journal-title":"Kidney Int"},{"issue":"1","key":"5222_CR106","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/08968608231196033","volume":"44","author":"RT Krediet","year":"2024","unstructured":"Krediet RT, Parikova A. Glucose-induced pseudohypoxia and advanced glycosylation end products explain peritoneal damage in long-term peritoneal dialysis. Perit Dial Int. 2024;44(1):6\u201315.","journal-title":"Perit Dial Int"},{"issue":"6","key":"5222_CR107","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/ndt\/14.6.1541","volume":"14","author":"K Honda","year":"1999","unstructured":"Honda K, Nitta K, Horita S, et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transpl. 1999;14(6):1541\u20139.","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"5222_CR108","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1681\/ASN.V12112434","volume":"12","author":"J Witowski","year":"2001","unstructured":"Witowski J, Wisniewska J, Korybalska K, et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol. 2001;12(11):2434\u201341.","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"5222_CR109","doi-asserted-by":"publisher","first-page":"8607","DOI":"10.3390\/ijms25168607","volume":"25","author":"Y Ito","year":"2024","unstructured":"Ito Y, Sun T, Tawada M, et al. Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis. Int J Mol Sci. 2024;25(16):8607. https:\/\/doi.org\/10.3390\/ijms25168607.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5222_CR110","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/life15020279","volume":"15","author":"K Hashimoto","year":"2025","unstructured":"Hashimoto K, Kamijo Y. Current Progress in Peritoneal Dialysis: A Narrative Review of Progress in Peritoneal Dialysis Fluid. Life (Basel). 2025;15(2):279. https:\/\/doi.org\/10.3390\/life15020279.","journal-title":"Life (Basel)"},{"key":"5222_CR111","doi-asserted-by":"publisher","unstructured":"Elphick EH, Teece L, Chess JA et al. Biocompatible solutions and long-term changes in peritoneal solute transport. Clin J Am Soc Nephrol. 2018;13(10):1526\u20131533. Erratum in: Clin J Am Soc Nephrol. 2019;14(6):909. https:\/\/doi.org\/10.2215\/CJN.02830319.","DOI":"10.2215\/CJN.02830319"},{"issue":"6","key":"5222_CR112","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1053\/j.jrn.2018.08.006","volume":"28","author":"JJ Carrero","year":"2018","unstructured":"Carrero JJ, Thomas F, Nagy K, et al. Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018;28(6):380\u201392.","journal-title":"J Ren Nutr"},{"issue":"5","key":"5222_CR113","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/cs0730471","volume":"73","author":"TH Goodship","year":"1987","unstructured":"Goodship TH, Lloyd S, McKenzie PW, et al. Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci (Lond). 1987;73(5):471\u20138.","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"5222_CR114","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/ki.1989.109","volume":"35","author":"M Bruno","year":"1989","unstructured":"Bruno M, Bagnis C, Marangella M, Rovera L, Cantaluppi A, Linari F. CAPD with an amino acid dialysis solution: a long-term, cross-over study. Kidney Int. 1989;35(5):1189\u201394.","journal-title":"Kidney Int"},{"issue":"1","key":"5222_CR115","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/089686089001000120","volume":"10","author":"NV Dombros","year":"1990","unstructured":"Dombros NV, Prutis K, Tong M, et al. Six-month overnight intraperitoneal amino-acid infusion in continuous ambulatory peritoneal dialysis (CAPD) patients\u2013no effect on nutritional status. Perit Dial Int. 1990;10(1):79\u201384.","journal-title":"Perit Dial Int"},{"key":"5222_CR116","doi-asserted-by":"publisher","unstructured":"Tjiong HL, Swart R, Van den Berg JW, Fieren MW. Dialysate as food as an option for automated peritoneal dialysis. NDT Plus. 2008;1(Suppl 4):iv36-iv40. https:\/\/doi.org\/10.1093\/ndtplus\/sfn122. PMID.","DOI":"10.1093\/ndtplus\/sfn122"},{"key":"5222_CR117","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1038\/sj.ki.5002614","volume":"108","author":"M Asola","year":"2008","unstructured":"Asola M, Virtanen K, N\u00e5gren K, et al. Amino-acid-based peritoneal dialysis solution improves amino-acid transport into skeletal muscle. Kidney Int Suppl. 2008;108:S131\u20136.","journal-title":"Kidney Int Suppl"},{"issue":"7","key":"5222_CR118","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.2215\/CJN.08550814","volume":"10","author":"D Marcelli","year":"2015","unstructured":"Marcelli D, Usvyat LA, Kotanko P, et al. MONitoring Dialysis Outcomes (MONDO) Consortium. Body composition and survival in dialysis patients: results from an international cohort study. Clin J Am Soc Nephrol. 2015;10(7):1192\u2013200.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"13","key":"5222_CR119","first-page":"409","volume":"136","author":"S Opatrn\u00e1","year":"1997","unstructured":"Opatrn\u00e1 S, Liska J, V\u00edt L, Hostasov\u00e1 A, Opatrn\u00fd K Jr. The effect of dialysis solutions containing amino acids on the nutritional status of patients treated with continuous ambulatory peritoneal dialysis. Cas Lek Cesk. 1997;136(13):409\u201312.","journal-title":"Cas Lek Cesk"},{"issue":"3","key":"5222_CR120","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrneph.2012.12","volume":"8","author":"SH Han","year":"2012","unstructured":"Han SH, Han DS. Nutrition in patients on peritoneal dialysis. Nat Rev Nephrol. 2012;8(3):163\u201375.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"5222_CR121","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/nu12061715","volume":"12","author":"T Kiebalo","year":"2020","unstructured":"Kiebalo T, Holotka J, Habura I, Pawlaczyk K. Nutritional Status in Peritoneal Dialysis: Nutritional Guidelines, Adequacy and the Management of Malnutrition. Nutrients. 2020;12(6):1715. https:\/\/doi.org\/10.3390\/nu12061715.","journal-title":"Nutrients"},{"issue":"6","key":"5222_CR122","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1053\/j.akdh.2023.12.008","volume":"30","author":"A Shammas","year":"2023","unstructured":"Shammas A, Joshi S, Shah AD. Nutrition in Peritoneal Dialysis. Adv Kidney Dis Health. 2023;30(6):537\u201345.","journal-title":"Adv Kidney Dis Health"},{"issue":"6","key":"5222_CR123","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.amjmed.2019.10.031","volume":"133","author":"A Eckart","year":"2020","unstructured":"Eckart A, Struja T, Kutz A, et al. Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective Study. Am J Med. 2020;133(6):713\u2013e7227.","journal-title":"Am J Med"},{"issue":"2","key":"5222_CR124","first-page":"152","volume":"53","author":"AM Cueto Manzano","year":"2001","unstructured":"Cueto Manzano AM. Hypoalbuminemia in dialysis. Is it a marker for malnutrition or inflammation? Rev Invest Clin. 2001;53(2):152\u20138.","journal-title":"Rev Invest Clin"},{"key":"5222_CR125","doi-asserted-by":"crossref","unstructured":"Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004 Nov-Dec;17(6):432\u20137.","DOI":"10.1111\/j.0894-0959.2004.17603.x"},{"issue":"4","key":"5222_CR126","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1523-1755.2004.00520.x","volume":"65","author":"GA Kaysen","year":"2004","unstructured":"Kaysen GA, Dubin JA, M\u00fcller HG, Rosales L, Levin NW, Mitch WE, HEMO Study Group NIDDK. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int. 2004;65(4):1408\u201315.","journal-title":"Kidney Int"},{"issue":"6","key":"5222_CR127","doi-asserted-by":"publisher","first-page":"e33143","DOI":"10.5812\/numonthly.33143","volume":"7","author":"V Krishnamoorthy","year":"2015","unstructured":"Krishnamoorthy V, Sunder S, Mahapatra HS, et al. Evaluation of Protein-Energy Wasting and Inflammation on Patients Undergoing Continuous Ambulatory Peritoneal Dialysis and its Correlations. Nephrourol Mon. 2015;7(6):e33143. https:\/\/doi.org\/10.5812\/numonthly.33143.","journal-title":"Nephrourol Mon"},{"key":"5222_CR128","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.clnesp.2022.03.033","volume":"49","author":"AM Cueto-Manzano","year":"2022","unstructured":"Cueto-Manzano AM, Romero-Garc\u00eda ARJ, Cort\u00e9s-Sanabria L, et al. Systemic inflammation May limit the effect of protein supplement on nutritional status in peritoneal dialysis. Clin Nutr ESPEN. 2022;49:307\u201313.","journal-title":"Clin Nutr ESPEN"},{"issue":"Suppl 2","key":"5222_CR129","doi-asserted-by":"publisher","first-page":"S435","DOI":"10.1177\/089686089901902S71","volume":"19","author":"A Canepa","year":"1999","unstructured":"Canepa A, Verrina E, Perfumo F, et al. Value of intraperitoneal amino acids in children treated with chronic peritoneal dialysis. Perit Dial Int. 1999;19(Suppl 2):S435\u201340.","journal-title":"Perit Dial Int"},{"issue":"5","key":"5222_CR130","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1046\/j.1523-1755.2001.0590051967.x","volume":"59","author":"A Canepa","year":"2001","unstructured":"Canepa A, Carrea A, Menoni S, et al. Acute effects of simultaneous intraperitoneal infusion of glucose and amino acids. Kidney Int. 2001;59(5):1967\u201373.","journal-title":"Kidney Int"},{"issue":"11","key":"5222_CR131","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1681\/ASN.2012100987","volume":"24","author":"PK Li","year":"2013","unstructured":"Li PK, Culleton BF, Ariza A, et al. IMPENDIA and EDEN Study Groups. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol. 2013;24(11):1889\u2013900.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5222_CR132","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0272-6386(12)80816-X","volume":"23","author":"S Arfeen","year":"1994","unstructured":"Arfeen S, Goodship TH, Kirkwood A, Channon S, Ward MK. 1% amino acid peritoneal dialysate: single-cycle study in diabetic patients with end-stage renal disease. Am J Kidney Dis. 1994;23(1):86\u201390.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"5222_CR133","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/089686089901900309","volume":"19","author":"IU Qamar","year":"1999","unstructured":"Qamar IU, Secker D, Levin L, Balfe JA, Zlotkin S, Balfe JW. Effects of amino acid dialysis compared to dextrose dialysis in children on continuous cycling peritoneal dialysis. Perit Dial Int. 1999;19(3):237\u201347.","journal-title":"Perit Dial Int"},{"issue":"2","key":"5222_CR134","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000014314","volume":"16","author":"CE Douma","year":"1998","unstructured":"Douma CE, Imholz AL, Struijk DG, Krediet RT. Similarities and differences between the effects of amino acids and nitroprusside on peritoneal permeability during CAPD. Blood Purif. 1998;16(2):57\u201365.","journal-title":"Blood Purif"},{"key":"5222_CR135","doi-asserted-by":"crossref","unstructured":"Olszowska A, Waniewski J, Werynski A, Anderstam B, Lindholm B, Wankowicz Z. Peritoneal transport in peritoneal dialysis patients using glucose-based and amino acid-based solutions. Perit Dial Int. 2007 Sep-Oct;27(5):544\u201353.","DOI":"10.1177\/089686080702700514"},{"issue":"Suppl 1","key":"5222_CR136","first-page":"1","volume":"44","author":"M Borr\u00e0s Sans","year":"2024","unstructured":"Borr\u00e0s Sans M, Ponz Clemente E, Rodr\u00edguez Carmona A, et al. Clinical guideline on adequacy and prescription of peritoneal dialysis. Nefrologia (Engl Ed). 2024;44(Suppl 1):1\u201327.","journal-title":"Nefrologia (Engl Ed)"},{"issue":"4","key":"5222_CR137","first-page":"192","volume":"33","author":"S Arfeen","year":"1990","unstructured":"Arfeen S, Goodship TH, Kirkwood A, Ward MK. The nutritional\/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution. Clin Nephrol. 1990;33(4):192\u20139.","journal-title":"Clin Nephrol"},{"issue":"8","key":"5222_CR138","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2215\/CJN.05410514","volume":"10","author":"S Yohanna","year":"2015","unstructured":"Yohanna S, Alkatheeri AM, Brimble SK, et al. Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2015;10(8):1380\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"5222_CR139","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3747\/pdi.2015.00031","volume":"37","author":"K Farhat","year":"2017","unstructured":"Farhat K, Douma CE, Ferrantelli E, Ter Wee PM, Beelen RHJ, van Ittersum FJ. Effects of Conversion to a Bicarbonate\/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial. Perit Dial Int. 2017;37(3):273\u201382.","journal-title":"Perit Dial Int"},{"issue":"3","key":"5222_CR140","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/089686080902900314","volume":"29","author":"A Davenport","year":"2009","unstructured":"Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002\u20132003. Perit Dial Int. 2009;29(3):297\u2013302.","journal-title":"Perit Dial Int"},{"issue":"5","key":"5222_CR141","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3747\/pdi.2012.00052","volume":"32","author":"DW Johnson","year":"2012","unstructured":"Johnson DW, Brown FG, Clarke M, et al. balANZ Trial Investigators. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial. Perit Dial Int. 2012;32(5):497\u2013506.","journal-title":"Perit Dial Int"},{"issue":"3","key":"5222_CR142","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/oxfordjournals.ndt.a027318","volume":"11","author":"SJ Davies","year":"1996","unstructured":"Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transpl. 1996;11(3):498\u2013506.","journal-title":"Nephrol Dial Transpl"},{"issue":"49","key":"5222_CR143","doi-asserted-by":"publisher","first-page":"e5569","DOI":"10.1097\/MD.0000000000005569","volume":"95","author":"Y Tian","year":"2016","unstructured":"Tian Y, Xie X, Xiang S, et al. Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: A retrospective study. Med (Baltim). 2016;95(49):e5569. https:\/\/doi.org\/10.1097\/MD.0000000000005569.","journal-title":"Med (Baltim)"},{"key":"5222_CR144","doi-asserted-by":"publisher","unstructured":"Li PK, Chow KM, Cho Y et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110\u2013153. Erratum in: Perit Dial Int. 2023;43(3):279. Erratum in: Perit Dial Int. 2024;44(3):223. https:\/\/doi.org\/10.1177\/08968608241251453.","DOI":"10.1177\/08968608241251453"},{"issue":"6","key":"5222_CR145","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/ckj\/sfac012","volume":"15","author":"SWY So","year":"2022","unstructured":"So SWY, Chen L, Woo AYH, et al. Stability and compatibility of antibiotics in peritoneal dialysis solutions. Clin Kidney J. 2022;15(6):1071\u20138.","journal-title":"Clin Kidney J"},{"issue":"2","key":"5222_CR146","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/ckj\/sfac131","volume":"16","author":"CW Ling","year":"2022","unstructured":"Ling CW, Sud K, Patel RP, Peterson GM, Castelino RL. Stability and compatibility of antibiotics in PD solutions-call for including antibiotics for drug-resistant infections. Clin Kidney J. 2022;16(2):394\u20135.","journal-title":"Clin Kidney J"},{"key":"5222_CR147","doi-asserted-by":"publisher","unstructured":"Ling CW, Sud K, Patel RP, et al. WCN23-0811 Stability of narrow-spectrum antibiotics in peritoneal dialysis solutions. Kidney International Reports. 2023;8(2) supplement:S356-S357. https:\/\/doi.org\/10.1016\/j.ekir.2023.02.802. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2468024923008525. Last accessed December 2, 2025. Pages S356-S357.","DOI":"10.1016\/j.ekir.2023.02.802"},{"key":"5222_CR148","unstructured":"NCT07077538. A prospective study of amino acid dialysate in diabetic peritoneal dialysis patients. Available in: https:\/\/www.clinicaltrials.gov\/study\/NCT07077538. Last accessed December 2, 2025."},{"key":"5222_CR149","unstructured":"NCT06597201. Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition. Available: https:\/\/clinicaltrials.gov\/study\/NCT06597201 Last accessed December 2, 2025."},{"issue":"2","key":"5222_CR150","doi-asserted-by":"publisher","first-page":"e101697","DOI":"10.1136\/bmjopen-2025-101697","volume":"16","author":"J Zhou","year":"2026","unstructured":"Zhou J, Jiang W, Zhang X, et al. Multicentre, open-label, prospective, parallel-controlled study protocol evaluating the effects of amino acid peritoneal dialysis solution on nutritional status in Chinese peritoneal dialysis patients. BMJ Open. 2026;16(2):e101697. https:\/\/doi.org\/10.1136\/bmjopen-2025-101697.","journal-title":"BMJ Open"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05222-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05222-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05222-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:07:35Z","timestamp":1785514055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05222-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5222"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05222-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research at Renal Medicine, Karolinska Institutet, is supported by a grant from Vantive to Karolinska Institutet. MLN: Received honoraria for lectures sponsored by Baxter\/Vantive. AB: Received honoraria for lectures sponsored by Baxter\/Vantive. The other authors do not declare any competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"449"}}